Wound healing adverse events in kidney transplant recipients receiving everolimus with reduced calcineurin inhibitor exposure or current standard-of-care: Insights from the 24 month TRANSFORM study
- Franco Citterio*
- , Mitchell Henry
- , Dean Y. Kim
- , Myoung Soo Kim
- , Duck Jong Han
- , Takashi Kenmochi
- , Eytan Mor
- , Giuseppe Tisone
- , Peter Bernhardt
- , Maria Pilar Hernandez Gutierrez
- , Yoshihiko Watarai
*Corresponding author for this work
- Catholic University of Sacred Heart
- Ohio State University
- Henry Ford Health System
- Yonsei University
- University of Ulsan
- Fujita Health University
- Sheba Medical Center at Tel Hashomer
- University of Rome Tor Vergata
- Novartis
- Japanese Red Cross Nagoya Daini Hospital
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations